Relationship between serum bilirubin levels and optic neuritis
Background Bilirubin is the end product of heme catabolism and has strong antioxidant properties. Serum bilirubin levels are reported to be reduced in patients with multiple sclerosis （MS） and neuromyelitis optica （NMO）. The pathophysiology of optic neuritis （ON） resembles that of MS; however, the r...
Gespeichert in:
| Veröffentlicht in: | Chinese medical journal Jg. 126; H. 17; S. 3307 - 3310 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
China
Department of Ophthalmology
2013
Multiple Sclerosis Center, Third Affiliated Hospital of Sun Yat-sen University,Guangzhou, Guangdong 510630, China%State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong 510630,China%Department of Neurology, Third Affiliated Hospital of Sun Yat-sen University,Guangzhou, Guangdong 510630, China |
| Schlagworte: | |
| ISSN: | 0366-6999, 2542-5641, 2542-5641 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Background Bilirubin is the end product of heme catabolism and has strong antioxidant properties. Serum bilirubin levels are reported to be reduced in patients with multiple sclerosis （MS） and neuromyelitis optica （NMO）. The pathophysiology of optic neuritis （ON） resembles that of MS; however, the role of endogenous bilirubin in ON is unclear. The aim of this study is to measure serum bilirubin levels in patients with ON, and to investigate the correlation between ON and serum antioxidant status of bilirubin. Methods Serum levels of bilirubin were measured in 42 patients with ON, 50 patients with multiple sclerosis （MS）, 48 patients with neuromyelitis optica （NMO） and 48 healthy control subjects. Results Serum total bilirubin （Tbil）, direct bilirubin （Dbil） and indirect bilirubin （Ibil） levels in patients with ON were significantly lower than those in the healthy controls. However, no statistical significance was found between levels in the ON and MS, ON and NMO, and MS and NMO groups. In patients with ON, serum Tbil, Dbil, and Ibil levels were lower in those with recurrence or those with ON for a longer duration （〉1 year）. Moreover, Tbil, Dbil, and Ibil concentrations were lower in patients with papillitis than in those with retrobulbar type ON, but the differences were not statistically significant. Conclusions Low antioxidant status may exist in patients with ON. But serum levels of Tbil, Dbil, and Ibil did not correlate with clinical presentations, such as recurrence, duration of disease and subtypes of ON. Low antioxidant status already existed in MS or NMO patients before systemic symptoms appeared. |
|---|---|
| AbstractList | Background Bilirubin is the end product of heme catabolism and has strong antioxidant properties. Serum bilirubin levels are reported to be reduced in patients with multiple sclerosis （MS） and neuromyelitis optica （NMO）. The pathophysiology of optic neuritis （ON） resembles that of MS; however, the role of endogenous bilirubin in ON is unclear. The aim of this study is to measure serum bilirubin levels in patients with ON, and to investigate the correlation between ON and serum antioxidant status of bilirubin. Methods Serum levels of bilirubin were measured in 42 patients with ON, 50 patients with multiple sclerosis （MS）, 48 patients with neuromyelitis optica （NMO） and 48 healthy control subjects. Results Serum total bilirubin （Tbil）, direct bilirubin （Dbil） and indirect bilirubin （Ibil） levels in patients with ON were significantly lower than those in the healthy controls. However, no statistical significance was found between levels in the ON and MS, ON and NMO, and MS and NMO groups. In patients with ON, serum Tbil, Dbil, and Ibil levels were lower in those with recurrence or those with ON for a longer duration （〉1 year）. Moreover, Tbil, Dbil, and Ibil concentrations were lower in patients with papillitis than in those with retrobulbar type ON, but the differences were not statistically significant. Conclusions Low antioxidant status may exist in patients with ON. But serum levels of Tbil, Dbil, and Ibil did not correlate with clinical presentations, such as recurrence, duration of disease and subtypes of ON. Low antioxidant status already existed in MS or NMO patients before systemic symptoms appeared. Bilirubin is the end product of heme catabolism and has strong antioxidant properties. Serum bilirubin levels are reported to be reduced in patients with multiple sclerosis (MS) and neuromyelitis optica (NMO). The pathophysiology of optic neuritis (ON) resembles that of MS; however, the role of endogenous bilirubin in ON is unclear. The aim of this study is to measure serum bilirubin levels in patients with ON, and to investigate the correlation between ON and serum antioxidant status of bilirubin. Serum levels of bilirubin were measured in 42 patients with ON, 50 patients with multiple sclerosis (MS), 48 patients with neuromyelitis optica (NMO) and 48 healthy control subjects. Serum total bilirubin (Tbil), direct bilirubin (Dbil) and indirect bilirubin (Ibil) levels in patients with ON were significantly lower than those in the healthy controls. However, no statistical significance was found between levels in the ON and MS, ON and NMO, and MS and NMO groups. In patients with ON, serum Tbil, Dbil, and Ibil levels were lower in those with recurrence or those with ON for a longer duration (≥ 1 year). Moreover, Tbil, Dbil, and Ibil concentrations were lower in patients with papillitis than in those with retrobulbar type ON, but the differences were not statistically significant. Low antioxidant status may exist in patients with ON. But serum levels of Tbil, Dbil, and Ibil did not correlate with clinical presentations, such as recurrence, duration of disease and subtypes of ON. Low antioxidant status already existed in MS or NMO patients before systemic symptoms appeared. Background Bilirubin is the end product of heme catabolism and has strong antioxidant properties.Serum bilirubin levels are reported to be reduced in patients with multiple sclerosis (MS) and neuromyelitis optica (NMO).The pathophysiology of optic neuritis (ON) resembles that of MS; however,the role of endogenous bilirubin in ON is unclear.The aim of this study is to measure serum bilirubin levels in patients with ON,and to investigate the correlation between ON and serum antioxidant status of bilirubin.Methods Serum levels of bilirubin were measured in 42 patients with ON,50 patients with multiple sclerosis (MS),48 patients with neuromyelitis optica (NMO) and 48 healthy control subjects.Results Serum total bilirubin (Tbil),direct bilirubin (Dbil) and indirect bilirubin (Ibil) levels in patients with ON were significantly lower than those in the healthy controls.However,no statistical significance was found between levels in the ON and MS,ON and NMO,and MS and NMO groups.In patients with ON,serum Tbil,Dbil,and Ibil levels were lower in those with recurrence or those with ON for a longer duration (＞1 year).Moreover,Tbil,Dbil,and Ibil concentrations were lower in patients with papillitis than in those with retrobulbar type ON,but the differences were not statistically significant.Conclusions Low antioxidant status may exist in patients with ON.But serum levels of Tbil,Dbil,and Ibil did not correlate with clinical presentations,such as recurrence,duration of disease and subtypes of ON.Low antioxidant status already existed in MS or NMO patients before systemic symptoms appeared. Bilirubin is the end product of heme catabolism and has strong antioxidant properties. Serum bilirubin levels are reported to be reduced in patients with multiple sclerosis (MS) and neuromyelitis optica (NMO). The pathophysiology of optic neuritis (ON) resembles that of MS; however, the role of endogenous bilirubin in ON is unclear. The aim of this study is to measure serum bilirubin levels in patients with ON, and to investigate the correlation between ON and serum antioxidant status of bilirubin.BACKGROUNDBilirubin is the end product of heme catabolism and has strong antioxidant properties. Serum bilirubin levels are reported to be reduced in patients with multiple sclerosis (MS) and neuromyelitis optica (NMO). The pathophysiology of optic neuritis (ON) resembles that of MS; however, the role of endogenous bilirubin in ON is unclear. The aim of this study is to measure serum bilirubin levels in patients with ON, and to investigate the correlation between ON and serum antioxidant status of bilirubin.Serum levels of bilirubin were measured in 42 patients with ON, 50 patients with multiple sclerosis (MS), 48 patients with neuromyelitis optica (NMO) and 48 healthy control subjects.METHODSSerum levels of bilirubin were measured in 42 patients with ON, 50 patients with multiple sclerosis (MS), 48 patients with neuromyelitis optica (NMO) and 48 healthy control subjects.Serum total bilirubin (Tbil), direct bilirubin (Dbil) and indirect bilirubin (Ibil) levels in patients with ON were significantly lower than those in the healthy controls. However, no statistical significance was found between levels in the ON and MS, ON and NMO, and MS and NMO groups. In patients with ON, serum Tbil, Dbil, and Ibil levels were lower in those with recurrence or those with ON for a longer duration (≥ 1 year). Moreover, Tbil, Dbil, and Ibil concentrations were lower in patients with papillitis than in those with retrobulbar type ON, but the differences were not statistically significant.RESULTSSerum total bilirubin (Tbil), direct bilirubin (Dbil) and indirect bilirubin (Ibil) levels in patients with ON were significantly lower than those in the healthy controls. However, no statistical significance was found between levels in the ON and MS, ON and NMO, and MS and NMO groups. In patients with ON, serum Tbil, Dbil, and Ibil levels were lower in those with recurrence or those with ON for a longer duration (≥ 1 year). Moreover, Tbil, Dbil, and Ibil concentrations were lower in patients with papillitis than in those with retrobulbar type ON, but the differences were not statistically significant.Low antioxidant status may exist in patients with ON. But serum levels of Tbil, Dbil, and Ibil did not correlate with clinical presentations, such as recurrence, duration of disease and subtypes of ON. Low antioxidant status already existed in MS or NMO patients before systemic symptoms appeared.CONCLUSIONSLow antioxidant status may exist in patients with ON. But serum levels of Tbil, Dbil, and Ibil did not correlate with clinical presentations, such as recurrence, duration of disease and subtypes of ON. Low antioxidant status already existed in MS or NMO patients before systemic symptoms appeared. |
| Author | DENG Juan LIANG Xue-mei ZHANG Xiu-lan LING Shi-qi YANG Ting-ting LI Min PENG Fu-hua |
| AuthorAffiliation | Department of Ophthalmology , Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China Multiple Sclerosis Center, Department of Neurology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong 510630, China |
| AuthorAffiliation_xml | – name: Department of Ophthalmology; Multiple Sclerosis Center, Third Affiliated Hospital of Sun Yat-sen University,Guangzhou, Guangdong 510630, China%State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong 510630,China%Department of Neurology, Third Affiliated Hospital of Sun Yat-sen University,Guangzhou, Guangdong 510630, China |
| Author_xml | – sequence: 1 givenname: Juan surname: DENG fullname: DENG, Juan – sequence: 2 givenname: Xue-mei surname: LIANG fullname: LIANG, Xue-mei – sequence: 3 givenname: Xiu-lan surname: ZHANG fullname: ZHANG, Xiu-lan – sequence: 4 givenname: Shi-qi surname: LING fullname: LING, Shi-qi – sequence: 5 givenname: Ting-ting surname: YANG fullname: YANG, Ting-ting – sequence: 6 givenname: Min surname: LI fullname: LI, Min – sequence: 7 givenname: Fu-hua surname: PENG fullname: PENG, Fu-hua |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24033954$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkc1v1DAQxS1URLeFfwGFA4hL0vFH7PgAElrxJVWqVMHZcpxJ11HibO2ECv56ku5uD5w4zeX33sy8d0HOwhiQkLcUCq4kXLnBFl3hUwoFcClzqbUuGFAOFehnZMNKwfJSCnpGNk_AOblIqQNgZankC3LOBHCuS7EhH2-xt5MfQ9r5fVbj9IAYsoRxHrLa9z7OtQ9Zj7-wT5kNTTbuJ--ygHP0k08vyfPW9glfHecl-fnl84_tt_z65uv37afr3AmuptxK3XDKGlcrXSGrSnC0kapE4KBoo0tsWau0Y0xVSpSVRs24bKFBzoRUjl-SdwffBxtaG-5MN84xLBvNn50buvV_qoDqBXx_APdxvJ8xTWbwyWHf24DjnAwVnDMFmsGCvj6icz1gY_bRDzb-NqdwFuDDAXBxTCli-4RQMGsZZinDdGYtw6xZmzVrcypj0W__0Ts_PYY9Rev7_3Z5c3TZjeHu3i_Pn84QCpSUWvK_QWCfoQ |
| CitedBy_id | crossref_primary_10_1111_liv_13351 crossref_primary_10_3390_antiox12071465 crossref_primary_10_1016_j_aohep_2025_102117 crossref_primary_10_3390_antiox10101538 crossref_primary_10_3390_brainsci14090888 |
| Cites_doi | 10.1073/pnas.0813132106 10.1016/j.jocn.2011.02.023 10.1126/science.3029864 10.1002/ana.20703 10.1097/01.wno.0000223266.48447.1b 10.4049/jimmunol.181.3.1887 10.1167/iovs.06-0553 10.1007/s00018-012-1014-5 10.1212/01.wnl.0000216139.44259.74 10.1080/08923970802331943 10.1016/S0165-5728(03)00132-2 10.1038/eye.2011.81 10.1179/135100006X154978 10.1093/brain/awr128 10.1016/j.pathophys.2010.04.009 10.1136/bjo.2003.027664 10.1097/NRL.0b013e31816f27fe 10.1111/j.1468-1331.2011.03488.x |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3760/cma.j.issn.0366-6999.20130809 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Relationship between serum bilirubin levels and optic neuritis |
| EISSN | 2542-5641 |
| EndPage | 3310 |
| ExternalDocumentID | zhcmj201317019 24033954 10_3760_cma_j_issn_0366_6999_20130809 47076696 |
| Genre | Journal Article |
| GroupedDBID | --- -05 -0E -SE -S~ .55 .GJ 29B 2B. 2C~ 2RA 2WC 3V. 40I 53G 5GY 5RE 5VR 5VS 6J9 7X7 88E 8FI 8FJ 92F 92I 92L 92M 93N 93R 9D9 9DE AAHPQ AASCR ABASU ABCQX ABDIG ABUWG ABVCZ ABXLX ACGFO ACGFS ACILI ADGGA ADHPY ADPDF ADRAZ AENEX AFDTB AFKRA AFUIB AHMBA AHVBC AINUH AJIOK AJNWD ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI ANFDX AOHHW BENPR BPHCQ BVXVI C1A CAJEE CAJUS CCEZO CCPQU CHBEP CIEJG CQIGP CW9 DIK DIWNM EBS EEVPB EJD F5P FA0 FCALG FRP FYUFA GNXGY GQDEL GROUPED_DOAJ GX1 HLJTE HMCUK HYE IAO IHR IHW IKREB INH INR IPNFZ ITC JUIAU KQ8 L7B M1P M48 OK1 OPUJH OVD OVDNE OVEED OXXIT P2P P6G PIMPY PQQKQ PROAC PSQYO PV9 Q-- Q-4 R-E RIG RLZ RNS RPM RT5 RZL S.. T8U TCJ TEORI TGQ TR2 TSPGW U1F U1G U5E U5O UKHRP W2D W91 WFFXF X7J X7M XSB ZA5 ZGI ZXP ~WA 0R~ AAAAV AAIQE AAYXX ABZZY ACBKD ACXJB ADKSD AFBFQ AHQNM AJCLO AJZMW AKCTQ ALKUP AOQMC BQLVK CITATION OVT ALIPV CGR CUY CVF ECM EIF H13 NPM PHGZM PHGZT PJZUB PPXIY 7X8 4A8 PMFND PSX |
| ID | FETCH-LOGICAL-c437t-a69d312dcb798e2850c1d675e03071d95ef2f79c227874589e9236f0de32467c3 |
| ISICitedReferencesCount | 5 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000329015600020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0366-6999 2542-5641 |
| IngestDate | Thu May 29 03:55:56 EDT 2025 Thu Oct 02 14:52:56 EDT 2025 Mon Jul 21 05:56:32 EDT 2025 Sat Nov 29 04:24:30 EST 2025 Tue Nov 18 21:05:42 EST 2025 Wed Feb 14 10:26:06 EST 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 17 |
| Keywords | bilirubin antioxidant optic neuritis |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c437t-a69d312dcb798e2850c1d675e03071d95ef2f79c227874589e9236f0de32467c3 |
| Notes | optic neuritis; bilirubin; antioxidant 11-2154/R Background Bilirubin is the end product of heme catabolism and has strong antioxidant properties. Serum bilirubin levels are reported to be reduced in patients with multiple sclerosis （MS） and neuromyelitis optica （NMO）. The pathophysiology of optic neuritis （ON） resembles that of MS; however, the role of endogenous bilirubin in ON is unclear. The aim of this study is to measure serum bilirubin levels in patients with ON, and to investigate the correlation between ON and serum antioxidant status of bilirubin. Methods Serum levels of bilirubin were measured in 42 patients with ON, 50 patients with multiple sclerosis （MS）, 48 patients with neuromyelitis optica （NMO） and 48 healthy control subjects. Results Serum total bilirubin （Tbil）, direct bilirubin （Dbil） and indirect bilirubin （Ibil） levels in patients with ON were significantly lower than those in the healthy controls. However, no statistical significance was found between levels in the ON and MS, ON and NMO, and MS and NMO groups. In patients with ON, serum Tbil, Dbil, and Ibil levels were lower in those with recurrence or those with ON for a longer duration （〉1 year）. Moreover, Tbil, Dbil, and Ibil concentrations were lower in patients with papillitis than in those with retrobulbar type ON, but the differences were not statistically significant. Conclusions Low antioxidant status may exist in patients with ON. But serum levels of Tbil, Dbil, and Ibil did not correlate with clinical presentations, such as recurrence, duration of disease and subtypes of ON. Low antioxidant status already existed in MS or NMO patients before systemic symptoms appeared. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doi.org/10.3760/cma.j.issn.0366-6999.20130809 |
| PMID | 24033954 |
| PQID | 1433270920 |
| PQPubID | 23479 |
| PageCount | 4 |
| ParticipantIDs | wanfang_journals_zhcmj201317019 proquest_miscellaneous_1433270920 pubmed_primary_24033954 crossref_primary_10_3760_cma_j_issn_0366_6999_20130809 crossref_citationtrail_10_3760_cma_j_issn_0366_6999_20130809 chongqing_primary_47076696 |
| PublicationCentury | 2000 |
| PublicationDate | 2013-00-00 |
| PublicationDateYYYYMMDD | 2013-01-01 |
| PublicationDate_xml | – year: 2013 text: 2013-00-00 |
| PublicationDecade | 2010 |
| PublicationPlace | China |
| PublicationPlace_xml | – name: China |
| PublicationTitle | Chinese medical journal |
| PublicationTitleAlternate | Chinese Medical Journal |
| PublicationTitle_FL | Chinese Medical Journal |
| PublicationYear | 2013 |
| Publisher | Department of Ophthalmology Multiple Sclerosis Center, Third Affiliated Hospital of Sun Yat-sen University,Guangzhou, Guangdong 510630, China%State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong 510630,China%Department of Neurology, Third Affiliated Hospital of Sun Yat-sen University,Guangzhou, Guangdong 510630, China |
| Publisher_xml | – name: Department of Ophthalmology – name: Multiple Sclerosis Center, Third Affiliated Hospital of Sun Yat-sen University,Guangzhou, Guangdong 510630, China%State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong 510630,China%Department of Neurology, Third Affiliated Hospital of Sun Yat-sen University,Guangzhou, Guangdong 510630, China |
| References | Qi (R17-20-20231228) 2007; 48 Polman (R15-20-20231228) 2005; 58 Liu (R9-20-20231228) 2008; 181 Mirshafiey (R6-20-20231228) 2009; 31 Barron (R18-20-20231228) 2004; 88 Mancuso (R7-20-20231228) 2006; 11 Sorce (R19-20-20231228) 2012; 19 Pau (R2-20-20231228) 2011; 25 Stocker (R8-20-20231228) 1987; 235 Wingerchuk (R16-20-20231228) 2006; 66 Abou Zeid (R1-20-20231228) 2008; 14 Liu (R20-20-20231228) 2003; 139 Sedlak (R10-20-20231228) 2009; 106 Peng (R12-20-20231228) 2011; 18 Peng (R11-20-20231228) 2012; 19 Haider (R4-20-20231228) 2011; 134 Liu (R5-20-20231228) 2003; 139 Burton (R3-20-20231228) 2011; 18 Tsoi (R13-20-20231228) 2006; 26 |
| References_xml | – volume: 106 start-page: 5171 year: 2009 ident: R10-20-20231228 article-title: Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0813132106 – volume: 18 start-page: 1355 year: 2011 ident: R12-20-20231228 article-title: Serum bilirubin concentrations and multiple sclerosis. publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2011.02.023 – volume: 235 start-page: 1043 year: 1987 ident: R8-20-20231228 article-title: Bilirubin is an antioxidant of possible physiological importance. publication-title: Science doi: 10.1126/science.3029864 – volume: 58 start-page: 840 year: 2005 ident: R15-20-20231228 article-title: Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. publication-title: Ann Neurol doi: 10.1002/ana.20703 – volume: 26 start-page: 87 year: 2006 ident: R13-20-20231228 article-title: Immunohistochemical evidence of inducible nitric oxide synthase and nitrotyrosine in a case of clinically isolated optic neuritis. publication-title: J Neuroophthalmol doi: 10.1097/01.wno.0000223266.48447.1b – volume: 181 start-page: 1887 year: 2008 ident: R9-20-20231228 article-title: Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis. publication-title: J Immunol doi: 10.4049/jimmunol.181.3.1887 – volume: 48 start-page: 681 year: 2007 ident: R17-20-20231228 article-title: Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis. publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.06-0553 – volume: 19 start-page: 2387 year: 2012 ident: R19-20-20231228 article-title: Targeting NOX enzymes in the central nervous system: therapeutic opportunities. publication-title: Cell Mol Life Sci doi: 10.1007/s00018-012-1014-5 – volume: 66 start-page: 1485 year: 2006 ident: R16-20-20231228 article-title: Revised diagnostic criteria for neuromyelitis optica. publication-title: Neurology doi: 10.1212/01.wnl.0000216139.44259.74 – volume: 31 start-page: 13 year: 2009 ident: R6-20-20231228 article-title: Antioxidant therapy in multiple sclerosis. publication-title: Immunopharmacol Immunotoxicol doi: 10.1080/08923970802331943 – volume: 139 start-page: 27 year: 2003 ident: R5-20-20231228 article-title: Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis. publication-title: J Neuroimmunol doi: 10.1016/S0165-5728(03)00132-2 – volume: 25 start-page: 833 year: 2011 ident: R2-20-20231228 article-title: Optic neuritis. publication-title: Eye doi: 10.1038/eye.2011.81 – volume: 11 start-page: 207 year: 2006 ident: R7-20-20231228 article-title: Bilirubin: an endogenous scavenger of nitric oxide and reactive nitrogen species. publication-title: Redox Rep doi: 10.1179/135100006X154978 – volume: 134 start-page: 1914 year: 2011 ident: R4-20-20231228 article-title: Oxidative damage in multiple sclerosis lesions. publication-title: Brain doi: 10.1093/brain/awr128 – volume: 18 start-page: 81 year: 2011 ident: R3-20-20231228 article-title: Optic neuritis: a mechanistic view. publication-title: Pathophysiology doi: 10.1016/j.pathophys.2010.04.009 – volume: 88 start-page: 286 year: 2004 ident: R18-20-20231228 article-title: The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. publication-title: Br J Ophthalmol doi: 10.1136/bjo.2003.027664 – volume: 14 start-page: 207 year: 2008 ident: R1-20-20231228 article-title: Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations. publication-title: Neurologist doi: 10.1097/NRL.0b013e31816f27fe – volume: 19 start-page: 277 year: 2012 ident: R11-20-20231228 article-title: Low antioxidant status of serum uric acid, bilirubin and albumin in patients with neuromyelitis optica. publication-title: Eur J Neurol doi: 10.1111/j.1468-1331.2011.03488.x – volume: 139 start-page: 27 year: 2003 ident: R20-20-20231228 article-title: Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis. publication-title: J Neuroimmunol doi: 10.1016/S0165-5728(03)00132-2 |
| SSID | ssj0025576 |
| Score | 1.9787151 |
| Snippet | Background Bilirubin is the end product of heme catabolism and has strong antioxidant properties. Serum bilirubin levels are reported to be reduced in patients... Bilirubin is the end product of heme catabolism and has strong antioxidant properties. Serum bilirubin levels are reported to be reduced in patients with... Background Bilirubin is the end product of heme catabolism and has strong antioxidant properties.Serum bilirubin levels are reported to be reduced in patients... |
| SourceID | wanfang proquest pubmed crossref chongqing |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 3307 |
| SubjectTerms | Adolescent Adult Aged Antioxidants - metabolism Bilirubin - blood Child Child, Preschool Female Humans Male Middle Aged Multiple Sclerosis - blood Neuromyelitis Optica - blood Optic Neuritis - blood Young Adult 分解代谢 多发性硬化 抗氧化性能 氧化状态 水 神经炎 胆红素 血清 |
| Title | Relationship between serum bilirubin levels and optic neuritis |
| URI | http://lib.cqvip.com/qk/85656X/201317/47076696.html https://www.ncbi.nlm.nih.gov/pubmed/24033954 https://www.proquest.com/docview/1433270920 https://d.wanfangdata.com.cn/periodical/zhcmj201317019 |
| Volume | 126 |
| WOSCitedRecordID | wos000329015600020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2542-5641 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025576 issn: 0366-6999 databaseCode: DOA dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fa9RAEF5sleKL-NtUrRH0qaQm2WR_gAgiig-2KFTI25JsNr2UXu5615TiX-9MdrPGFqU--BKO3O0k7DfZm9l88w0hryiLawN_M1GaNRwSFNNElZA6yuumNCWv8qTKhmYT_OBAFIX86ni666GdAO86cXEhl_8VajgHYGPp7D_A7Y3CCfgMoMMRYIfjtYD39LYpDQuu3M93kQi76iEX3j1BrpCVZ14sUbMVdS1R3mgarGJvbbM29v37L5UJH_sax-btJ7ye1u0_F72J9k17ZV-6aPvoy_T3brt61kbf2ukWhK0d9UVXLGLS9jjyC6qtgR89h0_WR0ptj9vLCzdSc2Bi9bzcOx4s73nLSL-jENfK6TiY8uV8ABD1BKm0QtSXlLPHrzbIzZTnUowJt0vH85y7N9n2QlvktbuTN3-9D9SPdpZRkGO26I5OYbJ-D2yuZCtDUVjXwGRP4pfDu-SOSzzC99Zh7pEbprtPtvYdteIBeTf1m9D5TTj4Tej9JrR-E4LfhIPfhKPfPCTfP308_PA5cs01Ip1RfhaVTNY0SWtdcSlMKvJYJzVkjwZX_aSWuWnShkuNpdI8y4U0kAqwBp5sCMEZ1_QR2ewWnXlCQohaY1lrWUlBM8YqGdeC6hxC7bjOkjoJyLafJbW0Iioq4zFnTLKAvB2nTWknS4_dUU4UpKcIhgIwIEVFMBSCoRAMNYIREOaHj6avOfDliJGCFRVfk5WdWfRrSIYpTXks0zggjy143vQIfEBeODSVe_bW6sdMz4_R_NDiYPuPY5-S2ykSowai4jOyebbqzXNyS58DWKsdssELsTN46k9KP5-s |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relationship+between+serum+bilirubin+levels+and+optic+neuritis&rft.jtitle=Chinese+medical+journal&rft.au=Deng%2C+Juan&rft.au=Liang%2C+Xue-Mei&rft.au=Zhang%2C+Xiu-Lan&rft.au=Ling%2C+Shi-Qi&rft.date=2013&rft.issn=0366-6999&rft.volume=126&rft.issue=17&rft.spage=3307&rft_id=info:doi/10.3760%2Fcma.j.issn.0366-6999.20130809&rft_id=info%3Apmid%2F24033954&rft.externalDocID=24033954 |
| thumbnail_s | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85656X%2F85656X.jpg http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhcmj%2Fzhcmj.jpg |